Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ann N Y Acad Sci ; 1136: 12-20, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-17954668

RESUMEN

In the last 25 years, human immunodeficiency virus (HIV) has become the leading infectious killer of adults globally, with an estimated 44 million people infected with the virus worldwide. Most of these individuals live in poor regions of the world, particularly sub-Saharan Africa. Although a great deal of work has been done in identifying and treating individuals with the disease, there has been little action to date to address the complex socioeconomic factors that lie at the heart of this global pandemic. Understanding and responding to such factors is of paramount importance if HIV infection is to be managed in a meaningful way. This article explores the social context of people living with HIV in three different geographic and epidemiologic settings and highlights the social factors that shape and define an individual's risk of acquiring HIV. It also discusses unique programs aimed at addressing the complex realities of the world in which HIV thrives. These programs can act as models of HIV prevention and treatment.


Asunto(s)
Infecciones por VIH/tratamiento farmacológico , Medio Social , Adulto , Boston , Femenino , Salud Global , Infecciones por VIH/etiología , Infecciones por VIH/fisiopatología , Humanos , Lesotho , Masculino , Estudios de Casos Organizacionales , Perú , Pobreza , Factores de Riesgo , Factores Socioeconómicos
2.
Clin Infect Dis ; 38 Suppl 5: S429-36, 2004 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-15156434

RESUMEN

Like tuberculosis, human immunodeficiency virus (HIV) disease is associated with poverty and social inequalities, conditions that hamper the delivery of care. Like tuberculosis, treatment of HIV infection requires multidrug regimens, and the causative agent acquires drug resistance, which can be transmitted to others. A pilot project in rural Haiti introduced DOT-HAART (directly observed therapy with highly active antiretroviral therapy) for the care of patients with advanced acquired immune deficiency syndrome. A similar DOT-HAART effort was launched in Boston for patients with drug-resistant HIV disease who had experienced failure of unsupervised therapy. In both settings, community health promoters or accompagnateurs provide more than DOT: they offer psychosocial support and link patients to clinical staff and available resources. DOT-HAART in these 2 settings presents both challenges and opportunities. These models of care can be applied to other poverty-stricken populations in resource-poor settings.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Antituberculosos/uso terapéutico , Terapia por Observación Directa , Infecciones por VIH/tratamiento farmacológico , Tuberculosis/tratamiento farmacológico , Terapia Antirretroviral Altamente Activa , Boston , Servicios de Salud Comunitaria , Atención a la Salud , Farmacorresistencia Microbiana , Farmacorresistencia Viral , Infecciones por VIH/complicaciones , Haití , Humanos , Cooperación del Paciente , Proyectos Piloto , Pobreza , Resultado del Tratamiento , Tuberculosis/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA